ArticlePharmaceutics2025

An Evaluation of the Subcutaneous Depot Release of TV-46000, A Novel Long-Acting Injectable (LAI) Formulation of Risperidone, Under Extreme Conditions in Dogs, Minipigs and Humans.

Lilach Steiner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.